Eurofins expands into Asia-Pacific through QC services firm acquisition

By Dan Stanton contact

- Last updated on GMT

Related tags: Asia-pacific

Image: iStock
Image: iStock
Eurofins has bought Australian QC firm ams Laboratories in a push to expand its biopharma testing services into the Asia-Pacific region.

Sydney and Brisbane-based ams has been described by its new owners as “the leading independent analytical and cGMP Quality Control (QC) services provider for biopharmaceutical products and medical devices in Australia,”​ and will give Eurofins a strong entry platform for its own biopharmaceutical testing capabilities in the Asia-Pacific region.

“The acquisition of ams Laboratories provides Eurofins a platform to deploy its renowned capabilities in biopharmaceutical products testing in the Asia Pacific region, and reinforces the Group's global leadership in the biopharmaceutical products testing market,”​ said Eurofins CEO Gilles Martin.

“We look forward to expanding and strengthening ams Laboratories' footprint by providing them access to the full range of Eurofins' capabilities.”

The Australian firm generated revenues of over €5m ($6m) last year - the majority from biopharmaceutical products testing - and currently employs 45 staff across its two sites.

The acquisition is Eurofins’ second so far this year, after buying another QC testing firm – Sinensis Life Science BV – in January​ to further expand its global reach, and continues an M&A strategy which defined 2015 for the firm.

In June last year Eurofins announced it would pay $40m (€35m) for a 75% stake in Emory Genetics Laboratory (EGL) – a specialist provider of genetic testing service – in a deal with current owner Emory University's School of Medicine.

A week earlier the firm bought French testing services firm Biomnis from Bio Alfras SAS for €220m ($249m) and two weeks after it announced a €150m investment in lab group BioAccess.

And a month before that Eurofins acquired US-based testing services specialist Diatherix Laboratories.

Related news

Show more

Related products

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more